90. Rupp, H. A., & Wallen, K. (2007). Sex differences in viewing sexual stimuli: An eye-tracking study in men and women. Hormones and Behavior, 51(4), 524–533. doi:10.1016/j.yhbeh.2007.01.008.
91. Durante, K. M., Griskevicius, V., Hill, S. E. et al. (2011). Ovulation, female competition, and product choice: Hormonal influences on consumer behavior. Journal of Consumer Research, 37(6), 921–934. doi:10.1086/656575; Hill, S. E., Rodeheffer, C. D., Griskevicius, V. et al. (2012). Boosting beauty in an economic decline: Mating, spending, and the lipstick effect. Journal of Personality and Social Psychology, 103(2), 275–291. doi:10.1037/a0028657; Schmitt, D. P., & Buss, D. M. (1996). Strategic self-promotion and competitor derogation: Sex and context effects on the perceived effectiveness of mate attraction tactics. Journal of Personality and Social Psychology, 70(6), 1185–1204. doi:10.1037//0022-3514.70.6.1185.
92. Hill, S. E. & Durante, K. M. (2011). Courtship, Competition, and the Pursuit of Attractiveness: Mating Goals Facilitate Health-related Risk-Taking and Strategic Risk Suppression in Women. Personality and Social Psychology Bulletin, 37, 383–394. doi:10.1177/0146167210395603.
93. Miller, G. F. (2000). Evolution of human music through sexual selection. In N. L. Wallin, B. Merker, & S. Brown (Eds.), The origins of music (pp. 329–360). Cambridge, MA: MIT Press.
94. Wåhlin-Jacobsen, S., Kristensen, E., Pedersen, A. T. et al. (2017). Androgens and psychosocial factors related to sexual dysfunctions in premenopausal women. Journal of Sexual Medicine, 14(3), 366–379. doi:10.1016/j.jsxm.2016.12.237; Vale, F. C., Coimvra, B. B., Lopes, G. P., & Geber, S. (2017). Sexual dysfunction in premenopausal women could be related to hormonal profile. Gynecological Endocrinology, 33(2), 145–147. doi:10.1080/09513590.2016.1226793.
95. Zimmerman, Y., Eijkemans, M. J., Bennink, H. J. et al. (2013). The effect of combined oral contraception on testosterone levels in healthy women: A systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. doi:10.1093/humupd/dmt038; Fern, M., Rose, D. P., & Fern, E. B. (1978). Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstetrics and Gynecology, 51(5), 541–544. doi:10.1097/00006250-197805000-00005; Aden, U., Jung-Hoffmann, C., & Kuhl, H. (1998). A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception, 58(2), 75–81. doi:10.1016/s0010-7824(98)00071-7; Wiegratz, I., Kutschera, E., Lee, J. et al. (2003). Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception, 67(1), 25–32. doi:10.1016/s0010-7824(02)00436-5; Ågren, U. M., Anttila, M., Mäenpää-Liukko, K. et al. (2011). Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. European Journal of Contraception and Reproductive Health Care, 16(6), 458–467. doi:10.3109/13625187.2011.614363.
96. Zimmerman, Y., Eijkemans, M. J., Bennink, H. J. et al. (2013). The effect of combined oral contraception on testosterone levels in healthy women: A systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105; Vange, N. V., Blankenstein, M., Kloosterboer, H. et al. (1990). Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception, 41(4), 345–352. doi:10.1016/0010-7824(90)90034-s; Coenen, C., Thomas, C., Borm, G. et al. (1996). Changes in androgens during treatment with four low-dose contraceptives. Contraception, 53(3), 171–176. doi:10.1016/0010-7824(96)00006-6; Greco, T., Graham, C. A., Bancroft, J. et al. (2007). The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25μg of ethinyl estradiol. Contraception, 76(1), 8–17. doi:10.1016/j.contraception.2007.04.002.
97. Aden, U., Jung-Hoffmann, C., & Kuhl, H. (1998). A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception, 58(2), 75–81. doi:10.1016/s0010-7824(98)00071-7; Alexander, G. (1990). Testosterone and sexual behavior in oral contraceptive users and nonusers: A prospective study. Hormones and Behavior, 24(3), 388–402. doi:10.1016/0018-506x(90)90017-r; Wiegratz, I., Jung-Hoffmann, C., & Kuhl, H. (1995). Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception, 51(6), 341–346. doi:10.1016/0010-7824(95)00098-u; Coenen, C., Thomas, C., Borm, G. et al. (1996). Changes in androgens during treatment with four low-dose contraceptives. Contraception, 53(3), 171–176. doi:10.1016/0010-7824(96)00006-6; Thorneycroft, I. H., Stanczyk, F. Z., Bradshaw, K. D. et al. (1999). Effect of low-dose oral contraceptives on androgenic markers and acne. Contraception, 60(5), 255–262. doi:10.1016/s0010-7824(99)00093-1; Edwards, D. A., & Oneal, J. L. (2009). Oral contraceptives decrease saliva testosterone but do not affect the rise in testosterone associated with athletic competition. Hormones and Behavior, 56(2), 195–198. doi:10.1016/j.yhbeh.2009.01.008.
98. Fern, M., Rose, D. P., & Fern, E. B. (1978). Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstetrics and Gynecology, 51(5), 541–544. doi:10.1097/00006250-197805000-00005; Madden, J. D., Milewich, L., Parker, C. et al. (1978). The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate. American Journal of Obstetrics and Gynecology, 132(4), 380–384. doi:10.1016/0002-9378(78)90771-8; Carlström, K., Karlsson, R., & Schoultz, B. V. (2002). Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scandinavian Journal of Clinical and Laboratory Investigation, 62(5), 361–368. doi:10.1080/00365510260296519; Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility. Philadelphia: Lippincott Williams & Wilkins; Davison, S., & Bell, R. (2006). Androgen physiology. Seminars in Reproductive Medicine, 24(2), 71–77. doi:10.1055/s-2006-939565; Kuhl, H., Gahn, G., Romberg, G. et al. (1985). A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels. Contraception, 31(6), 583–593. doi:10.1016/0010-7824(85)90058-7; Jung-Hoffmann, C., Heidt, F., & Kuhl, H. (1988). Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75μg gestodene or 150μg desogestrel upon various hormonal parameters. Contraception, 38(6), 593–603. doi:10.1016/0010-7824(88)90044-3; Aden, U., Jung-Hoffmann, C., & Kuhl, H. (1998). A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception, 58(2), 75–81. doi:10.1016/s0010-7824(98)00071-7.
